Literature DB >> 18199869

Clinical decisions. Management of type 2 diabetes.

Ronald B Goldberg1, Rury Holman, Daniel J Drucker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18199869     DOI: 10.1056/NEJMclde0708469

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Design of Potent and Orally Active GPR119 Agonists for the Treatment of Type II Diabetes.

Authors:  Ping Liu; Zhiyong Hu; Byron G DuBois; Christopher R Moyes; David N Hunter; Cheng Zhu; Nam Fung Kar; Yuping Zhu; Joie Garfunkle; Ling Kang; Gary Chicchi; Anka Ehrhardt; Andrea Woods; Toru Seo; Morgan Woods; Margaret van Heek; Karen H Dingley; Jianmei Pang; Gino M Salituro; Joyce Powell; Jenna L Terebetski; Viktor Hornak; Louis-Charles Campeau; Joe Lamberson; Fez Ujjainwalla; Michael Miller; Andrew Stamford; Harold B Wood; Timothy Kowalski; Ravi P Nargund; Scott D Edmondson
Journal:  ACS Med Chem Lett       Date:  2015-07-10       Impact factor: 4.345

2.  Quality of life and satisfaction with treatment in subjects with type 2 diabetes: results from primary health care in Turkey.

Authors:  Aclan Ozder; Mesut Sekeroglu; Hasan Huseyin Eker
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis.

Authors:  Archana S Rao; Banny S Wong; Michael Camilleri; Suwebatu T Odunsi-Shiyanbade; Sanna McKinzie; Michael Ryks; Duane Burton; Paula Carlson; Jesse Lamsam; Ravinder Singh; Alan R Zinsmeister
Journal:  Gastroenterology       Date:  2010-08-04       Impact factor: 22.682

4.  N of 1 trials in diabetes: making individual therapeutic decisions.

Authors:  A Tsapas; D R Matthews
Journal:  Diabetologia       Date:  2008-04-04       Impact factor: 10.122

Review 5.  New drugs for type 2 diabetes mellitus: what is their place in therapy?

Authors:  Andrew J Krentz; Mayank B Patel; Clifford J Bailey
Journal:  Drugs       Date:  2008       Impact factor: 9.546

6.  Role of growth hormone-releasing hormone in dyslipidemia associated with experimental type 1 diabetes.

Authors:  Maritza J Romero; Rudolf Lucas; Huijuan Dou; Supriya Sridhar; Istvan Czikora; Eby M Mosieri; Ferenc G Rick; Norman L Block; Subbaramiah Sridhar; David Fulton; Neal L Weintraub; Zsolt Bagi; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

Review 7.  Early insulin treatment in type 2 diabetes: what are the pros?

Authors:  Luigi F Meneghini
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

8.  Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study.

Authors:  M J Davies; R Donnelly; A H Barnett; S Jones; C Nicolay; A Kilcoyne
Journal:  Diabetes Obes Metab       Date:  2009-12       Impact factor: 6.577

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.